In the study by Zanini et al., there were fewer CD68+ and CD8 + cells in bronchial biopsies in COPD patients using ICS compared to patients without ICS, and also vascularity, assessed with vascular endothelial growth factor positive (VEGF+) cells, was decreased in ICS users [17]. The gene discussed is CD68; the disease is chronic obstructive pulmonary disease.